Cargando…

Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography

Purpose: Women whose mammographic breast density declines within 12–18 months of initiating tamoxifen for chemoprevention or adjuvant treatment show improved therapeutic responses compared with those whose density is unchanged. We tested whether measuring changes in sound speed (a surrogate of breas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gierach, Gretchen L., Sak, Mark, Fan, Shaoqi, Pfeiffer, Ruth M., Palakal, Maya, Ramin, Cody, Bey-Knight, Lisa, Simon, Michael S., Gorski, David, Ali, Haythem, Littrup, Peter, Sherman, Mark E., Duric, Nebojsa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836554/ https://www.ncbi.nlm.nih.gov/pubmed/35160244 http://dx.doi.org/10.3390/jcm11030792

Ejemplares similares

Short-term changes in ultrasound tomography measures of breast density and treatment-associated endocrine symptoms after tamoxifen therapy
por: Ramin, Cody, et al.
Publicado: (2023)

Using Whole Breast Ultrasound Tomography to Improve Breast Cancer Risk Assessment: A Novel Risk Factor Based on the Quantitative Tissue Property of Sound Speed
por: Duric, Neb, et al.
Publicado: (2020)

The Potential Role of the Fat–Glandular Interface (FGI) in Breast Carcinogenesis: Results from an Ultrasound Tomography (UST) Study
por: Duric, Nebojsa, et al.
Publicado: (2021)

Multicenter Study of Whole Breast Stiffness Imaging by Ultrasound Tomography (SoftVue) for Characterization of Breast Tissues and Masses
por: Littrup, Peter J., et al.
Publicado: (2021)

Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients
por: Mullooly, Maeve, et al.
Publicado: (2019)

Application of convolutional neural networks to breast biopsies to delineate tissue correlates of mammographic breast density
por: Mullooly, Maeve, et al.
Publicado: (2019)

Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients
por: Sherman, Mark E., et al.
Publicado: (2016)

Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992–2016
por: Ramin, Cody, et al.
Publicado: (2021)

Relationship of Serum Progesterone and Progesterone Metabolites with Mammographic Breast Density and Terminal Ductal Lobular Unit Involution among Women Undergoing Diagnostic Breast Biopsy
por: Hada, Manila, et al.
Publicado: (2020)

Host, reproductive, and lifestyle factors in relation to quantitative histologic metrics of the normal breast
por: Abubakar, Mustapha, et al.
Publicado: (2023)

Outdoor air pollution and terminal duct lobular involution of the normal breast
por: Niehoff, Nicole M., et al.
Publicado: (2020)

Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing image-guided breast biopsy
por: Bodelon, Clara, et al.
Publicado: (2021)

Relationship of circulating insulin-like growth factor-I and binding proteins 1–7 with mammographic density among women undergoing image-guided diagnostic breast biopsy
por: Hada, Manila, et al.
Publicado: (2019)

Risk factors for breast cancer development by tumor characteristics among women with benign breast disease
por: Figueroa, Jonine D., et al.
Publicado: (2021)

Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast
por: Bodelon, Clara, et al.
Publicado: (2020)

Mammographic Breast Density and Breast Cancer Molecular Subtypes: The Kenyan-African Aspect
por: Shaikh, Asim Jamal, et al.
Publicado: (2018)

Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease
por: Horne, Hisani N., et al.
Publicado: (2016)

Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort
por: Wang, Shao-Ming, et al.
Publicado: (2020)

Tamoxifen Resistance in Breast Cancer
por: Chang, Minsun
Publicado: (2012)

Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis
por: Felix, Ashley S., et al.
Publicado: (2016)

Beyond Breast Cancer: Mammographic Features and Mortality Risk in a Population of Healthy Women
por: Murphy, Rachel A., et al.
Publicado: (2013)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

Association between mammographic density and basal-like and luminal A breast cancer subtypes
por: Razzaghi, Hilda, et al.
Publicado: (2013)

Histiocytic lymphoma of breast responds to tamoxifen.
por: Millis, R. R., et al.
Publicado: (1988)

Adjuvant tamoxifen for early breast cancer.
por: Smith, I.
Publicado: (1988)

The mechanism of tamoxifen in breast cancer prevention
por: Yu, F, et al.
Publicado: (2001)

Breast cancer chemoprevention: beyond tamoxifen
por: Fabian, Carol J
Publicado: (2001)

SAT-LB130 Tamoxifen Affects MiRNA Expression in Uterus and Breast Tamoxifen Affects MiRNA Expression in Uterus and Breast Tamoxifen Affects MiRNA Expression in Uterus and Breast
por: Gulyaeva, Lyudmila, et al.
Publicado: (2020)

Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort
por: Ramin, Cody, et al.
Publicado: (2023)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

Decreasing Incidence of Estrogen Receptor–Negative Breast Cancer in the United States: Trends by Race and Region
por: Davis Lynn, Brittny C, et al.
Publicado: (2021)

Proceedings: Hormones in breast cancer patients on tamoxifen.
por: Golder, M. P., et al.
Publicado: (1975)

Influence of the antioestrogen tamoxifen on normal breast tissue.
por: Walker, K. J., et al.
Publicado: (1991)

Adjuvant tamoxifen for male breast cancer (MBC).
por: Ribeiro, G., et al.
Publicado: (1992)

Tamoxifen for women at high risk of breast cancer
por: Nazarali, Safia A, et al.
Publicado: (2014)

Combination Treatment of Tamoxifen with Risperidone in Breast Cancer
por: Yeh, Wei-Lan, et al.
Publicado: (2014)

Molecular prediction of tamoxifen resistance in breast cancer
por: Kok, M, et al.
Publicado: (2005)

Tamoxifen Action in ER-Negative Breast Cancer
por: Manna, Subrata, et al.
Publicado: (2016)

BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo
por: Cheng, Shujie, et al.
Publicado: (2017)

Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsy
por: Bodelon, Clara, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l4q6aeudbqlc2ol0skmdk6cde1